Project News Details
Title:
Hopes raised for next phase of AstraZeneca development in Cambridge after drugmaker commits to £300m spend in UK
Detail:
Firm reverses decision last year to halt spending because of concerns over drug pricing
Source:
Building
Published Date:
29.04.2026
Share:
Export requests Import requests Partnership requests Service requests